JSPR   $23.84  4.84% Market Closed After Close 23.91 0.29%

Jasper Therapeutics Inc
Total Cash 106.82M
totalCashPerShare 7.072
EBITDA -67.01M
Total Debt 2.32M
quickRatio 10.635
currentRatio 10.795
Total Revenue
debtToEquity 2.309
Revenue/Share
ROA -0.35779
ROE -0.59317
grossProfits
freeCashflow -34.78M
operatingCashflow -55.88M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 239.14M
forwardPE -5.4096384
floatShares 8.83M
sharesOutstanding 15.11M
sharesShort 2.00M
sharesShortPriorMonth 1.64M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.99%
Short Ratio help_outline 11.73%
shortPercentOfFloat 0.13%
impliedSharesOutstanding
bookValue 6.641
Price To Book help_outline 3.38
earningsQuarterlyGrowth
netIncomeToCommon -62.44M
trailingEps -60.72%
forwardEps -4.15%
enterpriseToEbitda -3.57
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.07 3Q 2024
institutionsCount 98
lastUpdated Sept. 16, 2024, 8:35 p.m.